Theme: Latest Trends in Pharmacy : Spanning the Gap in Research and Product Commercialization

Pharmaceutical Sciences 2017

Renowned Speakers

Pharmaceutical Sciences 2017

The Organizing Committee of Conference Series LLC invites all the participants across the globe to attend the 11th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry on February 27- 28, 2017 at AmsterdamNetherlands.

Track 1: Globalized Pharma Sector

Globalized Pharma Sector is based on gaining information on  changing structure of competition and increased competitiveness,  lack of brand new products,  despite increased investments into R&D (Research& Development) activities,  increased importance of regulatory issues (registrations, intellectual property rights, litigations),  fast consolidation and concentration of the world  Pharmaceutical industry can be known as the Globalized Pharma Sector.

Related Pharma Conferences | Pharmaceutical Meetings:

8th Global Pharmacovigilance  & Drug Safety Summit, April 17-18, 2017 Bali, Indonesia; 8th World Congress on Bioavailability & Bioequivalence: BA/BE Studies Summit, June 26-28, 2017 San Deigo, USA; 9th International Conference and Exhibition on Pharmacovigilance, July 17-19, 2017 Munich, Germany

Related Societies:

Pharmaceutical Society of IrelandThe International Society for Pharmaceutical Engineering (ISPE)The European Federation of Pharmaceutical Industries and Associations (EFPIA)The European Generic Medicines Association (EGA)The European Personalised Medicine Association EPEMEDEuropean Association of Employed Community Pharmacists in Europe (EPhEU)European Pharmaceutical Union (EPU)Pharmaceutical Group of the European Union (PGEU)

Track 2: Drug Discovery

In the fields of medicine, biotechnology and Pharmacology, drug discovery is the process by which new candidate medications are discovered. Modern drug discovery involves the identification of screening hits, medicinal chemistry and optimization of those hits to increase the affinity,  selectivity (to reduce the potential of side effects),  efficacy or potency,  metabolic stability  (to increase the half-life),  and oral bioavailability.

Related Pharma Conferences | Pharmaceutical Meetings:

8th Global Pharmacovigilance  & Drug Safety Summit, April 17-18, 2017 Bali, Indonesia; 8th World Congress on Bioavailability & Bioequivalence: BA/BE Studies Summit, June 26-28, 2017 San Deigo, USA; 9th International Conference and Exhibition on Pharmacovigilance, July 17-19, 2017 Munich, Germany.

Related Societies:

The European Generic Medicines Association (EGA)The European Personalised Medicine Association EPEMEDEuropean Association of Employed Community Pharmacists in Europe (EPhEU)European Pharmaceutical Union (EPU)Pharmaceutical Group of the European Union (PGEU)

Track 3: Drug Development

Drug development focusses on launch of new Pharmaceutical drug to the market once a lead compound has been identified through the process of drug discovery. It includes pre-clinical research on microorganisms and animals, filing for regulatory status, such as via the United States Food and Drug Administration for an investigational new drug to initiate clinical trials on humans, and may include the step of obtaining regulatory approval with a new drug application to market the drug.

Related Pharma Industry Meetings | Pharma Science Events:

8th World Congress on Bioavailability & Bioequivalence: BA/BE Studies Summit, June 26-28, 2017 San Deigo, USA; 9th International Conference and Exhibition on Pharmacovigilance, July 17-19, 2017 Munich, Germany; International Conference on Pharmaceutical and Biomedical Engineering June 12-13, 2017 Taipei, Taiwan; 10th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems March 13-15, 2017 London, UK; 10th Asia-Pacific Pharma Congress July 24-26, 2017 Melbourne, Australia; 6th World Congress on Pharmacology August 07-09, 2017 Paris, France.

Related Societies:

The International Society for Pharmaceutical Engineering (ISPE)The European Federation of Pharmaceutical Industries and Associations (EFPIA)The European Generic Medicines Association (EGA)The European Personalised Medicine Association EPEMED.

Track 4: Pharmaceutical Engineering

Pharmaceutical engineering deals with Pharmaceutical Science and technology that involves development and manufacturing of products, processes, and components in the Pharmaceuticals industry (i.e. drugs & biologics). While developing Pharmaceutical products involves many interrelated disciplines (e.g. medicinal chemists, analytical chemists, clinicians/pharmacologistspharmacists, chemical engineers, biomedical engineers, etc.), the specific subfield of "Pharmaceutical engineering" has only emerged recently as a distinct engineering discipline.

Related World Pharma Conference | Pharma Science Workshops:

8th World Congress on Bioavailability & Bioequivalence: BA/BE Studies Summit, June 26-28, 2017 San Deigo, USA; 9th International Conference and Exhibition on Pharmacovigilance, July 17-19, 2017 Munich, Germany; International Conference on Pharmaceutical and Biomedical Engineering June 12-13, 2017 Taipei, Taiwan; 10th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems March 13-15, 2017 London, UK; 10th Asia-Pacific Pharma Congress July 24-26, 2017 Melbourne, Australia; 6th World Congress on Pharmacology August 07-09, 2017 Paris, France.

Related Societies:

The European Federation of Pharmaceutical Industries and Associations (EFPIA)The European Generic Medicines Association (EGA)The European Personalised Medicine Association EPEMEDEuropean Association of Employed Community Pharmacists in Europe (EPhEU)European Pharmaceutical Union (EPU)Pharmaceutical Group of the European Union (PGEU).

Track 5: Advances in Pharmaceutical Packaging

Packaging plays an important role in providing protection, presentation, convenience, identification information, and compliance of a product during storage, transportation, display and until the product is safely consumed. Packaging may be considered as a system by which the product safely reaches from producer to consumer. The track mainly focuses on recent advances in packaging technology and packaging material. Many types of symbols for package labeling should be nationally and internationally standardized. Packaging symbols represent product certifications, trademarks, proof of purchase.

Related Pharma Conferences | Pharmaceutical Meetings:

8th World Congress on Bioavailability & Bioequivalence: BA/BE Studies Summit, June 26-28, 2017 San Deigo, USA; 9th International Conference and Exhibition on Pharmacovigilance, July 17-19, 2017 Munich, Germany; International Conference on Pharmaceutical and Biomedical Engineering June 12-13, 2017 Taipei, Taiwan; 10th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems March 13-15, 2017 London, UK; 10th Asia-Pacific Pharma Congress July 24-26, 2017 Melbourne, Australia; 6th World Congress on Pharmacology August 07-09, 2017 Paris, France.

Related Societies:

Pharmaceutical Society of IrelandThe International Society for Pharmaceutical Engineering (ISPE)The European Federation of Pharmaceutical Industries and Associations (EFPIA)The European Generic Medicines Association (EGA)The European Personalised Medicine Association EPEMED.

Track 6: Purpose and Principles of GMP 

Good Manufacturing Practices quality of drugs is essentially the responsibility of manufacturers. GMP Guidelines are means to assure this very quality of drugs. CGMP refers to the Current Good Manufacturing Practice regulations enforced by the US Food and Drug Administration (FDA). CGMPs provide for systems that assure proper design, monitoring, and control of manufacturing processes and facilities. Adherence to the CGMP regulations assures the identity, strength, quality, and purity of drug products by requiring that manufacturers of medications adequately control manufacturing operations. GMP is actually good common sense quality management quality assurance GMP production and quality control.

Related Pharma Industry Meetings | Pharma Science Events:

8th World Congress on Bioavailability & Bioequivalence: BA/BE Studies Summit, June 26-28, 2017 San Deigo, USA; 9th International Conference and Exhibition on Pharmacovigilance, July 17-19, 2017 Munich, Germany; International Conference on Pharmaceutical and Biomedical Engineering June 12-13, 2017 Taipei, Taiwan; 10th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems March 13-15, 2017 London, UK; 10th Asia-Pacific Pharma Congress July 24-26, 2017 Melbourne, Australia; 6th World Congress on Pharmacology August 07-09, 2017 Paris, France.

Related Societies:

Pharmaceutical Society of IrelandThe International Society for Pharmaceutical Engineering (ISPE)European Association of Employed Community Pharmacists in Europe (EPhEU)Pharmaceutical Group of the European Union (PGEU).

Track 7: Pharmaceutical Supply Chain Optimization

Supply chain management (SCM) is the integration of key business processes across the supply chain for the purpose of creating value for customers and stakeholders. Indeed supply chain management integrates supply and demand within and across companies in an efficient business model. The Council of Supply Chain Management Professionals defines supply chain management as planning and management of all activities involved in sourcing, procurement, conversion and all logistics activities. There are various aspects of optimizing in the supply chain; eliminating bottlenecks, balancing between lowest material cost and transportation, optimizing manufacturing flow, maintaining the right mix and location of factories and warehouses, vehicle routing analysis, dynamic programming and efficient use of capacities, inventories, and labours are of main aspects of supply chain optimization.

Related World Pharma Conference | Pharma Science Workshops:

8th World Congress on Bioavailability & Bioequivalence: BA/BE Studies Summit, June 26-28, 2017 San Deigo, USA; 9th International Conference and Exhibition on Pharmacovigilance, July 17-19, 2017 Munich, Germany; International Conference on Pharmaceutical and Biomedical Engineering June 12-13, 2017 Taipei, Taiwan; 10th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems March 13-15, 2017 London, UK; 10th Asia-Pacific Pharma Congress July 24-26, 2017 Melbourne, Australia; 6th World Congress on Pharmacology August 07-09, 2017 Paris, France.

Related Societies:

The European Generic Medicines Association (EGA)The European Personalised Medicine Association EPEMEDEuropean Association of Employed Community Pharmacists in Europe (EPhEU)European Pharmaceutical Union (EPU)Pharmaceutical Group of the European Union (PGEU).

Track 8Pharmaceutical Process Validation

Pharmaceutical Process Validation is the most important and recognized parameters of CGMPsQuality cannot be adequately assured by in-process and finished inspections and testing but it should be built in to the manufacturing process. These processes should be controlled in order that the finished product meets all quality specifications. Validation is one of the important steps in achieving and maintaining the quality of the final product. The requirement of process validation appears of the quality system (QS) regulation. The goal of a quality system is to consistently produce products that are fit for their intended use.

Related Pharma Sciences Conferences | Pharma Meetings:

8th World Congress on Bioavailability & Bioequivalence: BA/BE Studies Summit, June 26-28, 2017 San Deigo, USA; 9th International Conference and Exhibition on Pharmacovigilance, July 17-19, 2017 Munich, Germany; International Conference on Pharmaceutical and Biomedical Engineering June 12-13, 2017 Taipei, Taiwan; 10th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems March 13-15, 2017 London, UK; 10th Asia-Pacific Pharma Congress July 24-26, 2017 Melbourne, Australia; 6th World Congress on Pharmacology August 07-09, 2017 Paris, France.

Related Societies:

The International Society for Pharmaceutical Engineering (ISPE)The European Federation of Pharmaceutical Industries and Associations (EFPIA)The European Generic Medicines Association (EGA)The European Personalised Medicine Association EPEMED.

Track 9: Regulatory Requirements for Pharmaceuticals

The area unit variety of motives for extending the merchandise development outside of the mature, developed economies (e.g. the EU and therefore the US) and most of them have faith in the high population and market potential of rising markets. FDA guidance for clinical investigations and Pharmaceutical development goes a lot of and a lot of international within the direction of rising markets that tend to supply solutions for the patient achievement and overall development prices and timelines.

Related Pharma Conferences | Pharmaceutical Meetings:

8th World Congress on Bioavailability & Bioequivalence: BA/BE Studies Summit, June 26-28, 2017 San Deigo, USA; 9th International Conference and Exhibition on Pharmacovigilance, July 17-19, 2017 Munich, Germany; International Conference on Pharmaceutical and Biomedical Engineering June 12-13, 2017 Taipei, Taiwan; 10th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems March 13-15, 2017 London, UK; 10th Asia-Pacific Pharma Congress July 24-26, 2017 Melbourne, Australia; 6th World Congress on Pharmacology August 07-09, 2017 Paris, France.

Related Societies:

The European Federation of Pharmaceutical Industries and Associations (EFPIA)The European Generic Medicines Association (EGA)The European Personalised Medicine Association EPEMEDEuropean Association of Employed Community Pharmacists in Europe (EPhEU)European Pharmaceutical Union (EPU)Pharmaceutical Group of the European Union (PGEU).

Track 10: Medico Marketing

Medico-Marketing focusses on exchange of drug information among drug manufacturing company and the recommending doctor, Nurse, Pharmacist or with the end user. The intention behind this data exchange is to describe the Pharmaceutical Company’s products and how it will benefit the patient community in diagnosis or management of the human ailments.

Related Pharma Industry Meetings | Pharma Science Events:

8th World Congress on Bioavailability & Bioequivalence: BA/BE Studies Summit, June 26-28, 2017 San Deigo, USA; 9th International Conference and Exhibition on Pharmacovigilance, July 17-19, 2017 Munich, Germany; International Conference on Pharmaceutical and Biomedical Engineering June 12-13, 2017 Taipei, Taiwan; 10th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems March 13-15, 2017 London, UK; 10th Asia-Pacific Pharma Congress July 24-26, 2017 Melbourne, Australia; 6th World Congress on Pharmacology August 07-09, 2017 Paris, France.

Related Societies:

Pharmaceutical Society of IrelandThe International Society for Pharmaceutical Engineering (ISPE)The European Federation of Pharmaceutical Industries and Associations (EFPIA)The European Generic Medicines Association (EGA)The European Personalised Medicine Association EPEMED.

Track 11: Generics versus Big Pharma

Yet over the past decade in particular, most of the Big Pharmas have adopted small molecule generics in one shape or form into their overall business model. And many of them openly talk about the “innovation headroom” that a healthy low-priced generics market enables i.e. the money saved on off-patent drugs can be used to fund high-priced new innovations. They have recognized that they cannot fight the realities of aging populations and healthcare economics.

Related World Pharma Conference | Pharma Science Workshops:

8th World Congress on Bioavailability & Bioequivalence: BA/BE Studies Summit, June 26-28, 2017 San Deigo, USA; 9th International Conference and Exhibition on Pharmacovigilance, July 17-19, 2017 Munich, Germany; International Conference on Pharmaceutical and Biomedical Engineering June 12-13, 2017 Taipei, Taiwan; 10th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems March 13-15, 2017 London, UK; 10th Asia-Pacific Pharma Congress July 24-26, 2017 Melbourne, Australia; 6th World Congress on Pharmacology August 07-09, 2017 Paris, France.

Related Societies:

Pharmaceutical Society of IrelandThe International Society for Pharmaceutical Engineering (ISPE)European Association of Employed Community Pharmacists in Europe (EPhEU)Pharmaceutical Group of the European Union (PGEU).

Track 12: Pharma and Biotech Financial Outlook

The downturn in the global economy has forced Pharmaceutical and life sciences companies to focus on cost-saving initiatives, putting stress on finance departments. Although optimizing costs will always be important, reinvigorating R&D will most likely be a top strategic initiative for these companies as well. Most big Pharmaceutical companies are under competitive pressure from generic drug makers pressure that will become more intense as an increasing number of patents for “blockbuster” drugs expire during the next few years.

Related Pharmacovigilance Conferences | Pharma Science Summit:

8th World Congress on Bioavailability & Bioequivalence: BA/BE Studies Summit, June 26-28, 2017 San Deigo, USA; 9th International Conference and Exhibition on Pharmacovigilance, July 17-19, 2017 Munich, Germany; International Conference on Pharmaceutical and Biomedical Engineering June 12-13, 2017 Taipei, Taiwan; 10th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems March 13-15, 2017 London, UK; 10th Asia-Pacific Pharma Congress July 24-26, 2017 Melbourne, Australia; 6th World Congress on Pharmacology August 07-09, 2017 Paris, France.

Related Societies:

Pharmaceutical Society of IrelandThe International Society for Pharmaceutical Engineering (ISPE)The European Federation of Pharmaceutical Industries and Associations (EFPIA)The European Generic Medicines Association (EGA)The European Personalised Medicine Association EPEMEDEuropean Association of Employed Community Pharmacists in Europe (EPhEU)European Pharmaceutical Union (EPU)Pharmaceutical Group of the European Union (PGEU).

Track 13: Digital Pharma

Some of the people believes that digital capabilities are not only critical to Pharmaceutical companies’ ability to improve the way they roll out new products, but to increasing the Pharmaceutical industry’s contribution to health care by enabling it to provide innovative services to improve patients’ outcomes. In order to increase the perceived value of Pharma within the health care system, the industry is striving to respond to the needs of all stakeholders: health care professionals, patients and payors. In the meantime, the culture of Pharmaceutical companies is shifting from one of separate departments working vertically to one that is crossfunctional.

Related Pharma Conferences | Pharmaceutical Meetings:

8th World Congress on Bioavailability & Bioequivalence: BA/BE Studies Summit, June 26-28, 2017 San Deigo, USA; 9th International Conference and Exhibition on Pharmacovigilance, July 17-19, 2017 Munich, Germany; International Conference on Pharmaceutical and Biomedical Engineering June 12-13, 2017 Taipei, Taiwan; 10th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems March 13-15, 2017 London, UK; 10th Asia-Pacific Pharma Congress July 24-26, 2017 Melbourne, Australia; 6th World Congress on Pharmacology August 07-09, 2017 Paris, France.

Related Societies:

The European Generic Medicines Association (EGA)The European Personalised Medicine Association EPEMEDEuropean Association of Employed Community Pharmacists in Europe (EPhEU)European Pharmaceutical Union (EPU)Pharmaceutical Group of the European Union (PGEU).

Track 14: R&D Advancement: Road to New Medicines

Big pharmaceutical companies develop new business models to cope with the innovation crisis (patent loss, drying up of pipelines) and to improve their productivity in R&D and innovation. These pressures led big players to transform or reinvent their business models to sustain value creation from R&D and innovation. However, to our knowledge, there is still a lack of understanding regarding the “strategic alignment” of these organizational changes and on how they are perceived by organizational members.

Related Pharma Industry Meetings | Pharma Science Events:

8th World Congress on Bioavailability & Bioequivalence: BA/BE Studies Summit, June 26-28, 2017 San Deigo, USA; 9th International Conference and Exhibition on Pharmacovigilance, July 17-19, 2017 Munich, Germany; International Conference on Pharmaceutical and Biomedical Engineering June 12-13, 2017 Taipei, Taiwan; 10th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems March 13-15, 2017 London, UK; 10th Asia-Pacific Pharma Congress July 24-26, 2017 Melbourne, Australia; 6th World Congress on Pharmacology August 07-09, 2017 Paris, France.

Related Societies:

The International Society for Pharmaceutical Engineering (ISPE)The European Federation of Pharmaceutical Industries and Associations (EFPIA)The European Generic Medicines Association (EGA)The European Personalised Medicine Association EPEMED.

Track 15: Clinical Pharmacy and Therapeutics

Drug absorption is set by the drug’s chemistry properties, formulation, and route of administration. Dosage forms (e.g. tabletscapsules, solutions), consisting of the drug and alternative ingredients, square measure developed to lean by numerous routes (e.g. oral, buccal, sublingual, rectal, parenteral, topical, inhalational). In spite of the route of administration, medicine should be in answer to be absorbed.

Related World Pharma Conference | Pharma Science Workshops:

8th World Congress on Bioavailability & Bioequivalence: BA/BE Studies Summit, June 26-28, 2017 San Deigo, USA; 9th International Conference and Exhibition on Pharmacovigilance, July 17-19, 2017 Munich, Germany; International Conference on Pharmaceutical and Biomedical Engineering June 12-13, 2017 Taipei, Taiwan; 10th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems March 13-15, 2017 London, UK; 10th Asia-Pacific Pharma Congress July 24-26, 2017 Melbourne, Australia; 6th World Congress on Pharmacology August 07-09, 2017 Paris, France.

Related Societies:

The European Federation of Pharmaceutical Industries and Associations (EFPIA)The European Generic Medicines Association (EGA)The European Personalised Medicine Association EPEMEDEuropean Association of Employed Community Pharmacists in Europe (EPhEU)European Pharmaceutical Union (EPU)Pharmaceutical Group of the European Union (PGEU).

Track 16: Pharmaceutical Sciences

The pharmaceutical sciences combine broad range of scientific disciplines that are critical to the discovery and development of new drugs and therapies. Pharmaceutical Sciences is a dynamic and interdisciplinary field that aims to integrate fundamental principles of physical and organic chemistry, engineering, biochemistry, and biology to understand how to optimize delivery of drugs to the body and translate this integrated understanding into new and improved therapies against human disease. At the many of institutes internationally recognized faculty contribute to the field through inquiry into the underlying mechanisms of drug interactions with the human body and development of advanced synthetic or biologically-derived materials that can modulate these interactions in pursuit of better and safer therapies and drug products.

Related Pharmacovigilance Conferences | Pharma Science Summit:

8th World Congress on Bioavailability & Bioequivalence: BA/BE Studies Summit, June 26-28, 2017 San Deigo, USA; 9th International Conference and Exhibition on Pharmacovigilance, July 17-19, 2017 Munich, Germany; International Conference on Pharmaceutical and Biomedical Engineering June 12-13, 2017 Taipei, Taiwan; 10th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems March 13-15, 2017 London, UK; 10th Asia-Pacific Pharma Congress July 24-26, 2017 Melbourne, Australia; 6th World Congress on Pharmacology August 07-09, 2017 Paris, France.

Related Societies:

Pharmaceutical Society of IrelandThe International Society for Pharmaceutical Engineering (ISPE)The European Federation of Pharmaceutical Industries and Associations (EFPIA)The European Generic Medicines Association (EGA)The European Personalised Medicine Association EPEMED.

Track 17: Pharmaceutical Nanotechnology

Pharmaceutical Nanotechnology deals with emerging new technologies for developing customized solutions for drug delivery systems. The drug delivery system positively impacts the rate of absorption, distribution, metabolism, and excretion of the drug or other related chemical substances in the body. In addition to this the drug delivery system also allows the drug to bind to its target receptor and influence that receptor’s signaling and activity. Pharmaceutical nanotechnology embraces applications of nanoscience to pharmacy as nanomaterials, and as devices like drug delivery, diagnostic, imaging and biosensor.

Related Pharmacovigilance Conferences | Pharma Science Summit:            

8th World Congress on Bioavailability & Bioequivalence: BA/BE Studies Summit, June 26-28, 2017 San Deigo, USA; 9th International Conference and Exhibition on Pharmacovigilance, July 17-19, 2017 Munich, Germany; International Conference on Pharmaceutical and Biomedical Engineering June 12-13, 2017 Taipei, Taiwan; 10th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems March 13-15, 2017 London, UK; 10th Asia-Pacific Pharma Congress July 24-26, 2017 Melbourne, Australia; 6th World Congress on Pharmacology August 07-09, 2017 Paris, France.

Related Societies:

Pharmaceutical Society of IrelandThe International Society for Pharmaceutical Engineering (ISPE)European Association of Employed Community Pharmacists in Europe (EPhEU)Pharmaceutical Group of the European Union (PGEU).

Track 18: Entrepreneurs Investment Meet

A platform aimed to connect Entrepreneurs, Proposers and the Investors worldwide. It's intended to create and facilitate the most optimized and viable meeting place for engaging people in global business discussions, evaluation and execution of promising business ideas. An investor could be able to find out the highest potential investment opportunities globally, which provide good return on investment.

 

 

Following the tradition of successful Congresses held in several European countries, Dubai, Spain, Italy, India, South Africa and USA, the Organizing Committee of Conference Series LLC is pleased to invite all the participants across the globe to attend the 11th world Congress on Pharmaceutical Sciences and Innovations in Pharma Industry slated on February 27- 28, 2017 at Amsterdam, Netherlands.

The conference is a specially organized two day event which will provide a multi-channel communication platform that brings together both “producers” and “consumers” of pharma world of generic sector. It includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. It is a perfect platform for researchers, scientists and, delegates to share experience, foster collaborations across industry and academia, and evaluate emerging technologies across the globe.

Motives to attend:

  • Keynote presentation along with interactions to galvanize the scientific community.
  • Workshop and symposiums to reach the largest assemblage of participants from the Pharma community.
  • A wide track of exhibitors to showcase the new and emerging technologies.
  • Platform to global investment community to connect with stakeholders in Pharma sector.
  • Young Scientist/ Investigators Award geared towards best budding young research.
  • Links to the political marketing resources  in order to expand your business and research network.
  • Triumph of Awards, Certificates and CPD Credits recognizes your commitment to your profession to encourage the nascent research.

Target Audience:

  • Scientists
  • Pharmacists
  • Scholars from Pharmaceutical backgrounds
  • Business Tycoons
  • Students, Scientists, Researchers, and Faculty of Pharmaceutical Sciences, Universities and Medical Colleges
  • Researchers from Pharmaceutical Companies, Pharmacy Associations and Societies
  • Health professionals
  • Business development professionals, Consultants and Pharma service providers
  • Quality control specialist
  • Graduates and post graduates in industrial pharmacy
  • Medical Devices Manufacturing Companies, CRO
  • Data Management Companies.
  • Pharmaceutical legislators and regulators

Globalized growth of Pharmaceutical Research

Pharmaceuticals are one of the world's most beneficial ventures. Amid the most recent 30 years, the industry has burned through billions of dollars on research and procured billions consequently. In 2008 alone, the pharmaceutical business sold $773 billion in items around the world a number that has reliably developed for as long as 8 years and is anticipated to increment again by 2.5 to 3.5 percent in 2017, as per the medication statistical surveying firm IMS Health.

In any case, the procedure that transforms look into dollars into pharmaceuticals is a moderate and regularly strenuous one. It now takes a normal of 12 to 15 years and up to $1.7 billion for a medication to go from revelation to advertise, as indicated by The Pharmaceutical Research and Manufacturers of America. Also, regardless of constantly and cash contributed, just a modest bunch of medications are affirmed by the FDA every year.

The laborious medication endorsement prepare uncovers a focal truth about Big Pharma: it's a standout amongst the most seriously controlled businesses on the planet. The U.S. Nourishment and Drug Administration (FDA) and its European Union partner, the European Medicines Agency (EMEA), represent each part of a medication's improvement from chemicals utilized as a part of the medication and clinical study directions, called conventions, to bundling segments and showcasing materials. This strict oversight is intended to ensure persistent wellbeing, and pharma organizations consider administrative oversight important. The consistent weight to hold fast to government commands shapes each part of a pharma company's association, operations, and culture. For instance, sedate organizations keep up capable administrative undertakings divisions-the offices that arrangement with government offices and they have a tendency to be hazard disinclined.

 

 

The Pharmaceutical industry's long successful strategy of placing big bets on a few molecules, promoting them heavily and turning them into blockbusters worked well for many years, but its R&D productivity has now plummeted and the environment’s changing. There are few trends which are reshaping the marketplace.

Escalating demand for medicines

The global pharmaceutical market is growing steadily, with sales reaching $1.08 trillion in 2011 – a year-on-year increase of 7.8%. The mature economies proved very sluggish, but the growth economies were another matter. Sales in the BRIC countries (Brazil, China, India and Russia) rose by 22.6%, while sales in the other 13 growth countries (the ‘fast followers’, as we call them) rose by 7.2%.9 If this pattern continues, the market for medicines could be worth nearly $1.6 trillion by 2020. 10 Indeed, it could be worth even more. Demand for pharma’s products is rising dramatically, as the global population increases, ages and becomes more sedentary. In 2010, there were an estimated 6.9 billion people. By 2020, there will be more than 7.6 billion.11 And, if present trends are any guide, many of them will have health problems In short, there are more people – and more sick or elderly people – in the world today than ever before. More people have access to affordable healthcare than ever before. And, by 2020, access to healthcare may well be regarded everywhere as a basic human right.

 

 

 

Poor scientific productivity

Take the vexed issue of the industry’s scientific productivity. Although the number of new medicines  reaching the market picked up in 2011, pharma’s annual output has effectively flat lined for the past 10 years . Developing new medicines is becoming an increasingly expensive business, too, although precisely how expensive is the subject of fierce debate. In 2006, the Tufts Center for the Study of Drug Development put average costs per molecule at $1.24-1.32 billion.22 Various commentators have since challenged these figures, claiming that the real cost is anything from $75 million to $4 billion, although most people lean towards the higher end of the range.

 

 

So where does the industry now stand? It’s proved remarkably resilient, given the many problems it’s dealing with. But, in essence, it faces two overarching challenges. Tomorrow’s challenge is to develop new medicines that can prevent or cure currently incurable diseases. Today’s challenge is to get to tomorrow – and that’s a tall order in itself. Fortunately, there are a number of steps senior executives can take to help their companies reach 2020 and ready them for the opportunities the next decade brings.

Major Pharmaceutical Associations & Societies in Europe :

Pharmaceutical Society of Ireland

The International Society for Pharmaceutical Engineering (ISPE)

The European Federation of Pharmaceutical Industries and Associations (EFPIA)

The European Generic Medicines Association (EGA)

The European Personalised Medicine Association EPEMED

European Association of Employed Community Pharmacists in Europe (EPhEU)

European Pharmaceutical Union (EPU)

Pharmaceutical Group of the European Union (PGEU)

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date February 27- 28, 2017
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Closed Day 1 Day 2
Poster Opportunity Closed Click Here to View

Media Partners